Related Experiment Video
Updated: Oct 25, 2025

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
CDX2 inducible microRNAs sustain colon cancer by targeting multiple DNA damage response pathway factors
Swati Priya1, Ekjot Kaur1, Swati Kulshrestha1
1Signal Transduction Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110067, India.
Abstract:
Meta-analysis of transcripts in colon adenocarcinoma patient tissues led to the identification of a DNA damage responsive miR signature called DNA damage sensitive miRs (DDSMs). DDSMs were experimentally validated in the cancerous colon tissues obtained from an independent cohort of colon cancer patients and in multiple cellular systems with high levels of endogenous DNA damage. All the tested DDSMs were transcriptionally upregulated by a common intestine-specific transcription factor, CDX2. Reciprocally, DDSMs were repressed via the recruitment of HDAC1/2-containing complexes onto the CDX2 promoter. These miRs downregulated multiple key targets in the DNA damage response (DDR) pathway, namely BRCA1, ATM, Chk1 (also known as CHEK1) and RNF8. CDX2 directly regulated the DDSMs, which led to increased tumor volume and metastasis in multiple preclinical models. In colon cancer patient tissues, the DDSMs negatively correlated with BRCA1 levels, were associated with decreased probability of survival and thereby could be used as a prognostic biomarker. This article has an associated First Person interview with the first author of the paper.
Insights
Researchers identified DNA damage sensitive miRs (DDSMs) in colon cancer. These DDSMs, regulated by CDX2, impact DNA damage response (DDR) and patient survival, offering potential as a prognostic biomarker.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colon adenocarcinoma exhibits complex molecular alterations.
- DNA damage response (DDR) pathways are crucial in cancer development.
- MicroRNAs (miRs) play significant roles in gene regulation and cancer.
Purpose of the Study:
- To identify and characterize microRNA signatures responsive to DNA damage in colon cancer.
- To elucidate the regulatory mechanisms of these microRNAs.
- To evaluate their potential as prognostic biomarkers for colon cancer.
Main Methods:
- Meta-analysis of colon adenocarcinoma patient tissue transcriptomes.
- Experimental validation in independent patient cohorts and cellular models.
- Analysis of transcription factor (CDX2) and epigenetic modifier (HDAC1/2) interactions.
- Assessment of microRNA target genes within the DDR pathway.
- Correlation analysis with clinical data, including survival probability.
Main Results:
- Identification of a DNA damage sensitive miR (DDSM) signature.
- DDSMs are transcriptionally upregulated by CDX2 and repressed by HDAC1/2 complexes.
- DDSMs downregulate key DDR genes like BRCA1, ATM, CHEK1, and RNF8.
- CDX2-regulated DDSMs promote tumor growth and metastasis in preclinical models.
- DDSMs negatively correlate with BRCA1 and patient survival in colon cancer.
Conclusions:
- A novel DDSM signature regulated by CDX2 is identified in colon cancer.
- This DDSM signature plays a role in modulating the DNA damage response.
- DDSMs serve as potential prognostic biomarkers for colon cancer patients.
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

